WASHINGTON, D.C. (Wednesday, August 26, 2009) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the death of Senator Ted Kennedy (D, MA):
“BIO joins the nation in mourning the loss of Senator Ted Kennedy. A dedicated public servant for more than four decades, Senator Kennedy was well-known for his leadership on health care issues in the Senate. He was an indefatigable champion for universal access to health care as well as a strong supporter of government funding for medical research. He worked to ensure that the U.S. continues to lead the world in biotech innovation and to bring the benefits of that innovation to patients. We have lost a great leader and a legendary public servant.
"We send our sincere sympathy to his family, friends and colleagues.”
Upcoming BIO Events
BIO Investor Forum
October 28-29, 2009
San Francisco, CA
Advanced Business Development Course
October 30, 2009
BIO Europe International Partnering Conference
November 2-4, 2009
Pacific Rim Summit on Industrial Biotechnology and Bioenergy
November 8-11, 2009
BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world.